On both ends of Capitol, both parties warn big pharma on drug prices

New York Times

29 January 2019 - Price restraints are sure to face resistance from a small army of pharmaceutical lobbyists.

Members of Congress from both parties served notice on pharmaceutical companies on Tuesday that the days of unchecked drug-price increases were over and that they would be held politically accountable for exorbitant prices.

The new reality became apparent at simultaneous but separate hearings of House and Senate committees where law makers said that the relentless increases were unsustainable and unacceptable.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder